Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal

Frederick W. Thielen*, Nasuh C. Bueyuekkaramikli, Rob Riemsma, Debra Fayter, Nigel Armstrong, Ching-Yun Wei, Vanesa Huertas Carrera, Kate Misso, Gill Worthy, Jos Kleijnen, Isaac Corro Ramos

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)975-984
Number of pages10
JournalPharmacoeconomics
Volume37
Issue number8
DOIs
Publication statusPublished - Aug 2019

Keywords

  • GROUP PERSPECTIVE

Cite this